Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00572338 · ClinicalTrials.gov registry record

Therapeutic Research in Multiple Myeloma

A clinical trial, sponsored by University of Arkansas.

Completed
Registry status
6,388
Enrollment target

NCT00572338: Completed study, sponsored by University of Arkansas.

NCT00572338 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 6,388 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00572338 has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
6,388 participants
Enrollment target

Study Summary

The purpose of this study is to learn how myeloma cells grow and become a cancer, how to distinguish them from normal cells and how to eliminate these cells selectively.

Interventions

  • OTHER No drugs are involved

Trial Details

FieldValue
Enrollment Target 6,388 participants
Start Date 2003-08
Est. Completion 2015-03
University of Arkansas

318 total trials

What the finished NCT00572338 record still lists

NCT00572338 is an observational study that tracks outcomes without assigning an intervention. Its 6,388 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which No drugs are involved is the first listed.

NCT00572338 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00572338 about?

NCT00572338 is a clinical study titled "Therapeutic Research in Multiple Myeloma". The purpose of this study is to learn how myeloma cells grow and become a cancer, how to distinguish them from normal cells and how to eliminate these cells selectively.

What is the current status of trial NCT00572338?

This trial is currently completed. The enrollment target is 6,388 participants. The study started on 2003-08. Estimated completion is 2015-03.

What interventions are being tested in trial NCT00572338?

The interventions under investigation include: No drugs are involved (OTHER).

Who is sponsoring clinical trial NCT00572338?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00505245 · 6,500 participants

    New Assessment System in Measuring Symptom Distress in Cancer Patients

  • NCT06821009 · 6,500 participants · NA

    Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening

  • NCT05369429 · 6,516 participants · NA

    My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life

  • NCT04884802 · 6,254 participants · NA

    The GUARDIAN Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00572338, the US trial registry maintained by the National Library of Medicine. NCT00572338 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.